Familial haemophagocytic lymphohistiocytosis – Basic Information

Go back

Familial haemophagocytic lymphohistiocytosis is a rare genetic disorder where the immune system turns against the body instead of protecting it. This condition, often appearing in infancy, creates a dangerous storm of overactive immune cells that can damage vital organs and become life-threatening without prompt treatment.

How Common Is This Condition

Familial haemophagocytic lymphohistiocytosis is an extremely rare disorder that affects approximately 1 in 50,000 births worldwide each year. The condition can strike anyone, but it most commonly appears in infants and young children. About 70 percent of cases develop before a child reaches their first birthday, though symptoms can occasionally emerge later in childhood or even in adulthood.[1][2]

Among all forms of haemophagocytic lymphohistiocytosis, familial cases represent only about 25 percent of total diagnoses. The remaining 75 percent are secondary forms triggered by other medical conditions. However, the true frequency of this condition may be higher than reported, as it is often misdiagnosed or goes undetected due to its complex presentation that can mimic other serious illnesses like severe infections.[4]

The numbers of diagnosed cases appear to be gradually increasing over recent years. This rise likely reflects improved detection methods and greater awareness among doctors rather than an actual increase in the disease itself. Better genetic testing capabilities and more sophisticated diagnostic tools now allow medical professionals to identify cases that might have been missed in the past.[3]

What Causes Familial Haemophagocytic Lymphohistiocytosis

Familial haemophagocytic lymphohistiocytosis is caused by inherited genetic mutations that affect how the immune system functions. These mutations occur in specific genes that provide instructions for making proteins essential for the proper operation of certain immune cells. When these genes are faulty, the immune system loses its ability to regulate itself properly.[1]

Four main genes are responsible for most cases of familial haemophagocytic lymphohistiocytosis: PRF1, STX11, STXBP2, and UNC13D. Together, the PRF1 and UNC13D genes account for approximately 40 to 60 percent of all familial cases. The remaining cases are caused by mutations in the other known genes or, in some instances, by genetic defects that have not yet been identified.[2][1]

These genes normally help control the activity of lymphocytes, which are specialized white blood cells that fight infections, and macrophages, which are cells that engulf and destroy harmful invaders. The proteins produced by these genes help these immune cells destroy or deactivate themselves once their job is done. When the genes are mutated, the immune cells cannot shut down properly. They continue multiplying and remain overactive, releasing excessive amounts of inflammatory chemicals called cytokines. This uncontrolled immune response damages tissues and organs throughout the body.[2]

The condition follows an autosomal recessive inheritance pattern. This means a child must inherit two copies of the faulty gene—one from each parent—to develop the disease. Parents who each carry one mutated copy typically show no symptoms themselves. When both parents are carriers, each of their children has a 25 percent chance of developing the disease, a 50 percent chance of being a carrier like the parents, and a 25 percent chance of neither having the disease nor being a carrier.[2][6]

Risk Factors

The primary risk factor for familial haemophagocytic lymphohistiocytosis is having parents who both carry a mutated copy of one of the genes associated with the condition. Because this is an inherited genetic disorder, family history plays the central role in determining risk. If siblings of an affected child are tested, there is a strong likelihood that some may carry the genetic defect or even have the disease themselves.[1]

Infections often act as triggers that unmask the condition in children born with the genetic predisposition. While the genetic mutations are present from birth, symptoms typically appear when the immune system encounters an infection and attempts to respond. Common viral infections, including Epstein-Barr virus, can activate the disease process in children with the underlying genetic defect.[4][3]

Certain geographic or ethnic backgrounds may carry slightly higher risks due to population genetics. In communities where marriages between relatives are more common, the chance of both parents carrying the same genetic mutation increases. However, familial haemophagocytic lymphohistiocytosis has been documented across all ethnic groups and geographic regions worldwide.[2]

It is important to understand that parents cannot prevent this condition or predict its occurrence without genetic testing. The mutations happen randomly during the formation of eggs or sperm or are inherited from previous generations. No lifestyle choices, environmental exposures, or actions during pregnancy cause the genetic mutations that lead to familial haemophagocytic lymphohistiocytosis.[1]

⚠️ Important
If one child in a family has been diagnosed with familial haemophagocytic lymphohistiocytosis, siblings should be considered for genetic testing even if they show no symptoms. Early identification allows doctors to monitor these children closely and begin treatment immediately if symptoms develop, which can significantly improve outcomes.

Symptoms and Warning Signs

Familial haemophagocytic lymphohistiocytosis typically presents as a severe, rapidly progressing illness that resembles a serious infection. The most prominent symptom is persistent high fever that does not respond to antibiotics. This fever often continues for days or weeks and may reach very high temperatures, making parents understandably worried about their child’s condition.[1][4]

Children with this condition commonly develop an enlarged liver and spleen, medical terms for which are hepatomegaly and splenomegaly. Parents or doctors may notice that the child’s belly appears swollen or distended. The liver may not work properly, leading to yellowing of the skin and eyes called jaundice. Some children develop a rash, though this occurs less frequently than fever and organ enlargement.[1][4]

The bone marrow, where blood cells are produced, becomes damaged by the overactive immune system. This leads to cytopenias, which means abnormally low counts of various blood cell types. Children may develop anemia, or low red blood cells, making them appear pale, tired, and weak. Low platelet counts, called thrombocytopenia, can cause easy bruising, small red spots on the skin, or abnormal bleeding from the nose or gums.[2][4]

Neurological symptoms are particularly concerning and can include irritability, seizures, loss of muscle coordination, abnormal muscle tone, or changes in consciousness. In infants, the soft spots on the skull may remain open longer than normal. Older children might experience confusion, difficulty with movement, or in severe cases, paralysis. Some children may lose their vision or hearing. These symptoms indicate that the brain is being affected by the disease process.[2][1]

Enlarged lymph nodes, the small bean-shaped organs that are part of the immune system, may be felt in the neck, armpits, or groin. The child may appear generally unwell, with poor feeding, weight loss, or failure to grow and develop as expected. Breathing difficulties can occur if the condition affects the lungs or if severe anemia reduces the blood’s ability to carry oxygen.[4][3]

In some cases, the disease may develop before birth while the baby is still in the womb. However, most children appear normal at birth and develop symptoms within their first few months of life. The speed at which symptoms progress varies, but the disease generally worsens rapidly once it becomes active, making early recognition and treatment essential.[1]

Prevention Possibilities

Because familial haemophagocytic lymphohistiocytosis is a genetic disorder present from birth, there is no way to prevent a child from inheriting the condition if both parents carry the genetic mutation. The disease cannot be avoided through lifestyle changes, dietary modifications, or environmental precautions. The genetic defect is determined at conception, before parents even know they are expecting a child.[1]

However, families with a known history of the condition can pursue genetic counseling before planning to have children. Genetic testing can identify whether parents are carriers of the mutations associated with familial haemophagocytic lymphohistiocytosis. If both parents are found to be carriers, they can discuss their options with genetic counselors and make informed decisions about family planning. Some families may choose prenatal testing during pregnancy to determine whether an unborn child has inherited the condition.[1]

For families where one child has already been diagnosed, testing other siblings can help identify those who have the genetic mutations but have not yet developed symptoms. While this does not prevent the disease, it allows doctors to monitor these children closely and begin treatment at the first sign of symptoms, potentially before the condition becomes life-threatening. Early intervention can make a significant difference in outcomes.[6]

Avoiding exposure to infections does not prevent familial haemophagocytic lymphohistiocytosis, but it may help delay symptom onset in children with the genetic predisposition. Good hygiene practices, keeping up-to-date with recommended vaccinations, and avoiding contact with sick individuals are general health measures that benefit all children but hold particular importance for those with known genetic defects affecting the immune system.[4]

⚠️ Important
Newborn screening programs do not routinely test for familial haemophagocytic lymphohistiocytosis. Parents with a family history of the condition or who have previously had an affected child should inform their doctors so appropriate genetic testing can be arranged for future pregnancies or newborns.

What Happens in the Body

Under normal circumstances, the immune system protects the body by recognizing and destroying harmful invaders like bacteria and viruses. Specialized immune cells called natural killer cells and cytotoxic T lymphocytes identify infected or abnormal cells and eliminate them. Once these immune cells complete their work, they receive signals to stop functioning and die off, preventing damage to healthy tissues. This carefully controlled process keeps inflammation in check.[3]

In familial haemophagocytic lymphohistiocytosis, genetic mutations disrupt this regulatory process. The faulty genes prevent immune cells from manufacturing the correct proteins needed to shut down after completing their protective functions. Without these critical proteins, lymphocytes and macrophages continue multiplying and remain activated far longer than they should. These overactive cells infiltrate organs throughout the body, including the bone marrow, liver, spleen, and brain.[1][2]

As these immune cells accumulate, they release enormous quantities of cytokines, which are chemical messengers that normally coordinate immune responses. The excessive production of cytokines creates what doctors call a cytokine storm. This storm of inflammatory signals causes widespread damage to tissues and organs. The cytokines disrupt normal body functions, leading to fever, tissue destruction, and organ dysfunction.[3][7]

In the bone marrow, overactive macrophages begin consuming blood cells in a process called hemophagocytosis, which gives the disease its name. This destruction of blood cells explains why affected children develop anemia, low platelet counts, and sometimes reduced numbers of infection-fighting white blood cells. The loss of these blood cells creates a vicious cycle, as the body attempts to produce more but they continue to be destroyed.[2]

The liver and spleen become enlarged as they fill with activated immune cells. Liver function deteriorates, leading to elevated liver enzymes in blood tests and potentially causing jaundice. The spleen, which normally filters blood and removes old blood cells, becomes overwhelmed and enlarged. Multiple organ systems can be affected simultaneously, leading to multi-organ dysfunction, where the heart, kidneys, lungs, and other organs begin to fail.[1][4]

Laboratory tests reveal characteristic abnormalities that help doctors recognize the disease. Ferritin, a protein that stores iron, rises to extremely high levels during active disease. Triglycerides, a type of fat in the blood, become elevated. Fibrinogen, a protein needed for blood clotting, drops to dangerously low levels. These biochemical changes reflect the widespread inflammation and organ dysfunction occurring throughout the body.[4][6]

When the brain is affected, immune cells infiltrate nervous tissue and cause inflammation. This can lead to seizures, changes in consciousness, difficulties with movement and coordination, and damage to vision or hearing. The accumulation of inflammatory cells in the brain and spinal cord can be seen on imaging studies and in samples of spinal fluid. Neurological involvement is particularly dangerous and requires urgent treatment.[1]

Without treatment, this cascade of immune system overactivation and organ damage progresses rapidly. The median survival for untreated infants is less than two months after symptoms begin. Death typically results from progressive organ failure, severe bleeding due to low platelets and clotting problems, or overwhelming infections that the damaged immune system cannot control. The severity and speed of progression make familial haemophagocytic lymphohistiocytosis a medical emergency requiring immediate specialized care.[1][3]

Ongoing Clinical Trials on Familial haemophagocytic lymphohistiocytosis

References

https://www.ncbi.nlm.nih.gov/books/NBK1444/

https://medlineplus.gov/genetics/condition/familial-hemophagocytic-lymphohistiocytosis/

https://primaryimmune.org/understanding-primary-immunodeficiency/types-of-pi/hemophagocytic-lymphohistiocytosis-hlh

https://my.clevelandclinic.org/health/diseases/24292-hemophagocytic-lymphohistiocytosis

https://www.dana-farber.org/cancer-care/types/childhood-hemophagocytic-lymphohistiocytosis

https://en.wikipedia.org/wiki/Hemophagocytic_lymphohistiocytosis

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01621-x

FAQ

Can familial haemophagocytic lymphohistiocytosis be cured?

The only curative treatment for familial haemophagocytic lymphohistiocytosis is allogeneic hematopoietic stem cell transplantation, commonly called bone marrow transplant. This procedure replaces the faulty immune system with healthy donor cells. Before transplantation, patients receive chemotherapy and immunotherapy to control the active disease. While transplantation carries risks, newer treatment protocols have significantly improved survival rates compared to past decades.

How is familial HLH different from secondary HLH?

Familial HLH is caused by inherited genetic mutations present from birth, while secondary HLH develops as a complication of other conditions like infections, cancers, or autoimmune diseases in people without the genetic defects. Familial HLH typically appears in infancy or early childhood, whereas secondary HLH can occur at any age. The distinction is important because familial HLH requires bone marrow transplantation for cure, while secondary HLH may resolve with treatment of the underlying trigger.

What tests confirm the diagnosis of familial haemophagocytic lymphohistiocytosis?

Diagnosis involves multiple approaches including blood tests showing characteristic abnormalities like low blood cell counts, extremely high ferritin, elevated triglycerides, and low fibrinogen. Doctors may examine bone marrow samples to look for hemophagocytosis. Genetic testing identifies mutations in genes like PRF1, STX11, STXBP2, or UNC13D. Additional tests assess immune cell function, particularly natural killer cell activity and T-cell killing ability.

If both my children have familial HLH, what are the chances my next child will have it?

If both parents are carriers of the same genetic mutation, each pregnancy carries a 25 percent chance of producing a child with familial HLH, a 50 percent chance of a carrier child, and a 25 percent chance of a child who neither has the disease nor carries the mutation. These odds remain the same for every pregnancy regardless of previous outcomes. Genetic counseling and prenatal testing options are available to help families make informed decisions.

Can symptoms of familial HLH come and go, or is it always severe?

Once symptoms of familial HLH become active, the disease typically progresses rapidly and severely without treatment. However, before symptoms begin, children with the genetic mutations may appear completely healthy for months or years. Some children experience their first episode triggered by an infection. Without proper treatment including eventual bone marrow transplant, the condition does not spontaneously improve and will recur or progress.

🎯 Key Takeaways

  • Familial haemophagocytic lymphohistiocytosis is an extremely rare genetic condition affecting approximately 1 in 50,000 births, where inherited mutations cause the immune system to attack the body instead of protecting it.
  • The condition follows an autosomal recessive pattern, meaning both parents must carry a mutated gene for a child to develop the disease, with each pregnancy carrying a 25 percent risk.
  • Symptoms typically appear in infancy and include persistent high fever, enlarged liver and spleen, low blood cell counts, jaundice, neurological problems, and rapid deterioration without treatment.
  • The disease creates a dangerous “cytokine storm” where overactive immune cells release massive amounts of inflammatory chemicals, causing widespread organ damage and potentially multi-organ failure.
  • Without treatment, survival is typically less than two months after symptoms begin, but modern chemotherapy protocols followed by bone marrow transplantation have dramatically improved outcomes.
  • Four main genes—PRF1, UNC13D, STX11, and STXBP2—account for most familial cases, though genetic testing does not identify the cause in all affected children.
  • Early diagnosis through genetic testing of siblings in affected families allows for close monitoring and immediate treatment if symptoms develop, significantly improving chances of survival.
  • Bone marrow transplantation remains the only curative treatment, replacing the faulty immune system with healthy donor cells that can properly regulate immune responses.